Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma

PURPOSE: To explore the utility of diffusion and perfusion changes in primary renal cell carcinoma (RCC) after stereotactic ablative body radiotherapy (SABR) as an early biomarker of treatment response, using diffusion weighted (DWI) and dynamic contrast enhanced (DCE) MRI. METHODS: Patients enrolle...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Reynolds, Hayley M., Parameswaran, Bimal K., Finnegan, Mary E., Roettger, Diana, Lau, Eddie, Kron, Tomas, Shaw, Mark, Chander, Sarat, Siva, Shankar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6095575/
https://ncbi.nlm.nih.gov/pubmed/30114235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0202387
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi